Application of genomics and proteomics in drug target discovery

被引：3
作者：
Zhang, H. M. [1 ,4 ]
Nan, Z. R. [1 ,4 ]
Hui, G. Q. [1 ,4 ]
Liu, X. H. [2 ]
Sun, Y. [3 ,4 ]
机构：
[1] Shanxi Acad Agr Sci, Maize Res Inst, Xinzhou City, Peoples R China
[2] China West Normal Univ, Coll Life Sci, Nanchong City, Peoples R China
[3] Shanxi Acad Agr Sci, Biotechnol Res Ctr, Taiyuan, Shanxi, Peoples R China
[4] Minist Agr, Key Lab Crop Gene Resources & Germplasm Enhanceme, Beijing, Peoples R China
来源：
GENETICS AND MOLECULAR RESEARCH | 2014年 / 13卷 / 01期
关键词：
Drug target; Genomics; Proteomics; Gene medicine; ACUTE-RENAL-FAILURE; TECHNOLOGIES;
D O I：
10.4238/2014.January.10.11
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Gene medicine is making breakthroughs in health questions that have baffled humanity for centuries. To understand and utilize gene medicine, it is necessary to realize its action against targets at the molecular level. Currently, many methods can be used to discover drug targets; among these, genomic and proteomic methods are the two most important. In this study, we introduced how to discover drug targets by genomic and proteomic methods in detail. These contents are beneficial for understanding and utilizing the two methods to discover new drug targets of gene medicine.
引用
收藏
页码：198 / 204
页数：7
相关论文
共 19 条
[1]   Proteornics and genomics: Perspectives on drug and target discovery [J].
Ahn, Natalie G. ;
Wang, Andrew H-J .
CURRENT OPINION IN CHEMICAL BIOLOGY, 2008, 12 (01) :1-3
[2]   Recent Advances of Fluorescent Technologies for Drug Discovery and Development [J].
Chakraborty, Chiranjib ;
Hsu, Chi-Hsin ;
Wen, Zhi-Hong ;
Lin, Chan-Shing .
CURRENT PHARMACEUTICAL DESIGN, 2009, 15 (30) :3552-3570
[3]   Liver proteomics for therapeutic drug discovery: Inhibition of the cyclophilin receptor CD147 attenuates sepsis-induced acute renal failure [J].
Dear, James W. ;
Leelahavanichkul, Asada ;
Aponte, Angel ;
Hu, Xuzhen ;
Constant, Stephanie L. ;
Hewitt, Stephen M. ;
Yuen, Peter S. T. ;
Star, Robert A. .
CRITICAL CARE MEDICINE, 2007, 35 (10) :2319-2328
[4]   The use of gene array technology and proteomics in the search of new targets of diseases for therapeutics [J].
Ferrer-Alcon, Marcel ;
Arteta, David ;
Guerrero, M. Jose ;
Fernandez-Orth, Dietmar ;
Simon, Laureano ;
Martinez, Antonio .
TOXICOLOGY LETTERS, 2009, 186 (01) :45-51
[5]   Disease proteomics [J].
Hanash, S .
NATURE, 2003, 422 (6928) :226-232
[6]   Biomarker and drug-target discovery using proteomics in a new rat model of sepsis-induced acute renal failure [J].
Holly, M. K. ;
Dear, J. W. ;
Hu, X. ;
Schechter, A. N. ;
Gladwin, M. T. ;
Hewitt, S. M. ;
Yuen, P. S. T. ;
Star, R. A. .
KIDNEY INTERNATIONAL, 2006, 70 (03) :496-506
[7]   Polymeric Gene Delivery for Diabetic Treatment [J].
Kim, Sung Wan .
DIABETES & METABOLISM JOURNAL, 2011, 35 (04) :317-326
[8]   All about DIGE: quantification technology for differential-display 2D-gel proteomics [J].
Lilley, KS ;
Friedman, DB .
EXPERT REVIEW OF PROTEOMICS, 2004, 1 (04) :401-409
[9]   Innovation - Target discovery [J].
Lindsay, MA .
NATURE REVIEWS DRUG DISCOVERY, 2003, 2 (10) :831-838
[10]   High-resolution functional proteomics by active-site peptide profiling [J].
Okerberg, ES ;
Wu, JY ;
Zhang, BH ;
Samii, B ;
Blackford, K ;
Winn, DT ;
Shreder, KR ;
Burbaum, JJ ;
Patricelli, MP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (14) :4996-5001
12